Sponsors that centralise their product information will not only help pre-empt drug shortages but also improve their own capacity for collaboration through connected systems and data. 

New Platform Accelerates Move to Single View of Product Information 

Improving patient access to life-enhancing treatments is a central mission of companies ranging from the world’s largest biopharmas to early-stage biotechs. Each pursues its own path to get there. For some, the focus is responsibly-priced medicines. Others are amplifying patient voices during the medicine life cycle or using ESG bonds to reach underserved communities. 

Patient access to life-enhancing treatments is a struggle without being able to ensure the timely delivery of medicines. Between 2000 and 2018, Europe experienced a 20-fold increase in drug shortages. On average, each pharmacy in the European Union spends more than six hours a week dealing with scarce supplies of medicines; in some countries, they spend as much as 20 hours per week.